Analysis of Genetic and Non-genetic Predictors of Levodopa Induced Dyskinesia in Parkinson’s Disease

Background: Levodopa (L-Dopa), representing the therapeutic gold standard for the treatment of Parkinson disease (PD), is associated with side effects like L-Dopa induced dyskinesia (LID). Although several non-genetic and genetic factors have been investigated for association with LID risk, contrast...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Pharmacol
Main Authors: Tirozzi, Alfonsina, Modugno, Nicola, Palomba, Nicole Piera, Ferese, Rosangela, Lombardi, Alessia, Olivola, Enrica, Gialluisi, Alessandro, Esposito, Teresa
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8118664/
https://ncbi.nlm.nih.gov/pubmed/33995045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.640603
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares